Literature DB >> 12511356

Amniotic membrane transplantation with conjunctival autograft for recurrent pterygium.

Jun Shimazaki1, Koichi Kosaka, Shigeto Shimmura, Kazuo Tsubota.   

Abstract

OBJECTIVE: To study the effect of amniotic membrane transplantation (AMT) combined with either limbal autograft transplantation (LAT) or conjunctival autograft transplantation (CAT) in recurrent pterygium.
DESIGN: Retrospective, noncomparative, interventional case series. PARTICIPANTS: Twenty-seven eyes of 27 patients with recurrent pterygium. The mean number of prior surgeries was 3.1 (range, 1-10). Fifteen eyes each had restriction of ocular movement and symblepharon before surgery. INTERVENTION: Patients were treated by AMT with either LAT (n = 15) or CAT (n = 12). MAIN OUTCOME MEASURES: Recurrence of pterygium, improvement in ocular movement, and symblepharon formation.
RESULTS: Twenty-three (85.2%) of 27 eyes showed no recurrence with a mean observation period of 67.0 weeks. Fourteen eyes (93.3%) each showed improvement in ocular movement restriction and symblepharon after AMT. In four eyes that developed recurrence, three had LAT and one had CAT combined with AMT, suggesting that there was no difference in surgical outcome between LAT and CAT.
CONCLUSIONS: AMT with CAT is a safe and effective method for recurrent pterygium, especially that associated with ocular movement restriction and symblepharon. Considering the potential adverse effects associated with limbal excision, AMT plus CAT may be preferred over AMT plus LAT.

Entities:  

Mesh:

Year:  2003        PMID: 12511356     DOI: 10.1016/s0161-6420(02)01453-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  17 in total

1.  Comparison of conjunctival autograft transplantation and amniotic membrane transplantation for pterygium: a meta-analysis.

Authors:  Meiyan Li; Min Zhu; Yongfu Yu; Lan Gong; Naiqing Zhao; Mark J Robitaille
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-21       Impact factor: 3.117

2.  Long-term follow-up of transplantation of preserved limbal allograft and amniotic membrane for recurrent pterygium.

Authors:  Takashi Ono; Yosai Mori; Ryohei Nejima; Tadatoshi Tokunaga; Kazunori Miyata; Shiro Amano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-26       Impact factor: 3.117

Review 3.  Developments and current approaches in the treatment of pterygium.

Authors:  Dilek Hacıoğlu; Hidayet Erdöl
Journal:  Int Ophthalmol       Date:  2016-09-23       Impact factor: 2.031

4.  Mitomycin C, amniotic membrane transplantation and limbal conjunctival autograft for treating multirecurrent pterygia with symblepharon and motility restriction.

Authors:  Yu-Feng Yao; Wen-Ya Qiu; Yong-Ming Zhang; Scheffer C G Tseng
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-12       Impact factor: 3.117

5.  Randomised controlled study of conjunctival autograft versus amniotic membrane graft in pterygium excision.

Authors:  P Luanratanakorn; T Ratanapakorn; O Suwan-Apichon; R S Chuck
Journal:  Br J Ophthalmol       Date:  2006-07-12       Impact factor: 4.638

6.  Efficacy and Safety of a Large Conjunctival Autograft for Recurrent Pterygium.

Authors:  Jun Seok Lee; Sang Won Ha; Sung Yu; Gwang Ja Lee; Young Jeung Park
Journal:  Korean J Ophthalmol       Date:  2017-12

7.  Limbal conjunctival versus amniotic membrane in the intraoperative application of mitomycin C for recurrent pterygium: a randomized controlled trial.

Authors:  Rongxin Chen; Guofu Huang; Shu Liu; Wenfang Ma; Xiaofang Yin; Shiyou Zhou
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-20       Impact factor: 3.117

8.  The recurrence of pterygium after different modalities of surgical treatment.

Authors:  Abdelrahman G Salman; Dina Ezzat Mansour
Journal:  Saudi J Ophthalmol       Date:  2010-10-25

9.  Clinical outcome of combined conjunctival autograft transplantation and amniotic membrane transplantation in pterygium surgery.

Authors:  Tejsu Malla; Jing Jiang; Kai Hu
Journal:  Int J Ophthalmol       Date:  2018-03-18       Impact factor: 1.779

10.  [Treatment of severe recurrent symblepharopterygium: combined ipsilateral autologous limbus and homologous amniotic membrane transplantation].

Authors:  C Huchzermeyer; Z Gatzioufas; F E Kruse; B Seitz
Journal:  Ophthalmologe       Date:  2014-09       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.